HCAT - Health Catalyst Inc. Market Capitalization-to-Revenue Ratio

Brandmark of Health Catalyst Inc. (HCAT)

Health Catalyst, Inc. (HCAT) is implementing advanced cloud solutions for medical analytics to optimize clinic costs. The price-to-sales ratio trend visualizes the market valuation of assets, where the value of 0.40 determines this level. The company's tools consolidate fragmented data to save lives, and its status as an industry gold standard confirms the high level of trust that major hospital networks place in this intelligent partner.

HCAT Health Catalyst, Inc.: P/S Multiple in the range 07/04/2022 - 11/13/2026

Analytical breakdowns for Health Catalyst, Inc (HCAT)

- share price and consensus valuation forecast:
Fundamental company analysis:healthcatalyst.com HCAT
Brand item of Health Catalyst, Inc

The P/S valuation links the market capitalization of Health Catalyst, Inc. (HCAT) to its generated revenue, reflecting the premium investors are willing to pay for every dollar of sales within the growing medical cloud platform segment. A time-series analysis of the P/S ratio allows for a comparison of the business's current valuation with the dynamics of acquiring large hospital networks, determining whether market optimism regarding the effectiveness of reducing clients' operating expenses is justified.

Who Health Catalyst, Inc. competes with

VEEV (veeva.com) - Market Capitalization-to-Revenue Ratio|Doximity - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HQY|Waystar Inc. - P/S Multiple|CorVel Corp. (CRVL) - Market Cap to Revenue|PRVA: P/S Multiple|huronconsultinggroup.com (HURN) - P/S Multiple|Market Cap to Revenue CERT|OMCL (Omnicell Inc) - Market Cap to Sales Volume|P/S Multiple GDRX|P/S Multiple Schrodinger Corp (SDGR)|Price-to-Revenue Ratio Phreesia, Inc. PHR|omadahealth.com - Price-to-Revenue Ratio|EVH: Market Cap to Revenue|Price to Sales HealthStream Inc|Definitive Healthcare Inc. (DH) - Price-to-Revenue Ratio|CCSI - Price-to-Revenue Coefficient|Market Cap to Revenue AGL|ABSI (absci.com) - Market Cap to Sales Volume|Market Cap to Revenue SY (So-Young International Inc.)|NRC (NRC Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple SPOK (Spok Corp)|Price-to-Revenue Coefficient OptimizeRx Inc. (OPRX)|TBRG - Price-to-Revenue Ratio|SLP (simulations-plus.com) - Market Cap to Revenue Ratio|SOPH: P/S Multiple|Market Cap to Revenue CareCloud|Market Cap to Revenue RSSS|DLH Holdings Corp (DLHC) - Price-to-Revenue Coefficient|P/S Multiple ONMD|SCNX (scienture.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple HCTI (Healthcare Triangle, Inc.)|ISPC - Market Cap to Revenue|Bullfrog AI Holdings Inc - P/S Multiple|WORX - P/S Multiple|MSPR (MSP Recovery Inc) - Market Cap to Revenue|ICCT: Market Cap to Sales Volume|MEDS (TRxADE HEALTH) - P/S Multiple|Orgenesis Inc (ORGS) - Price-to-Revenue Coefficient|Market Cap to Revenue RCM (R1 RCM Inc.)|Market Cap to Sales Volume SHCR|Streamline Health Solutions - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SYRA|AMEH - Price-to-Revenue Ratio|Model N Inc (MODN) - Market Cap to Revenue|NXGN: P/S Multiple